<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03077178</url>
  </required_header>
  <id_info>
    <org_study_id>IB2016-01</org_study_id>
    <nct_id>NCT03077178</nct_id>
  </id_info>
  <brief_title>Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over</brief_title>
  <acronym>SARCOLD</acronym>
  <official_title>Evaluation of the Impact of Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status of Patients Aged 70 Years and Over</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Bergonié</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Bergonié</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to describe functional impact of surgery in elderly patients treated for lower-limb
      soft-tissue sarcoma, the investigators set up this project which aims to identify prognostic
      factors among geriatric and functional assessment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective cohort including 100 patients &gt; 70 year-old treated by surgery for
      lower-limb soft-tissue sarcoma. Data on clinical and geriatric characteristics of the patient
      as well as functional and quality of life assessment will be collected among patient
      participation (3 years). Primary endpoint is to describe evaluation of the Impact of
      Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2017</start_date>
  <completion_date type="Anticipated">March 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Physical functioning assessment</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>Quality of life questionnaire QLQ-C30</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional status assessment (TESS)</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>Toronto Extremity salvage score (TESS) Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status assessment (MST)</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>Muskuloskeletal Tumor Society (MST) scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until deterioration of physical functioning</measure>
    <time_frame>Change until 36 months after surgery</time_frame>
    <description>Quality of life questionnaire QLQ-C30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment QLQ-C30</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>Quality of life questionnaire QLQ-C30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment QLQ-EDL-14</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>Quality of life questionnaire QLQ-EDL-14</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric parameters assessment - G8</measure>
    <time_frame>baseline</time_frame>
    <description>G8 (onco-geratic screening score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric parameters assessment - CIRS-G</measure>
    <time_frame>baseline</time_frame>
    <description>CIRS-G (Cumulative Illness Rating Scale - Geriatrics)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric parameters assessment - MNA</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>MNA (Mini Nutritional Assessment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric parameters assessment - ADL</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>ADL (Activities in Daily Living)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric parameters assessment - IADL</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>IADL (Instrumental Activities in Daily Living)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric parameters assessment - GDS 15</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>GDS 15(Geriatric Depression Scale).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric parameters assessment - MMSE</measure>
    <time_frame>Change from baseline until 36 months after surgery</time_frame>
    <description>MMSE (Mini Mental Status)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Assessment</measure>
    <time_frame>Change from Baseline until 36 months after surgery</time_frame>
    <description>Brief Pain Inventory (BPI) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>Change from Day 0 until 12 months after surgery</time_frame>
    <description>classification Clavien Dindo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OS</measure>
    <time_frame>Change from Day 0 until 36 months after surgery</time_frame>
    <description>Overall Survival</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Soft Tissue Sarcoma Adult</condition>
  <arm_group>
    <arm_group_label>Prospective cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Geriatric assessment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Geriatric assessment</intervention_name>
    <description>Geriatric assessment, questionnaire assessment</description>
    <arm_group_label>Prospective cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged more than 70 years,

          2. Soft tissue sarcoma histologically proven,

          3. Sarcoma of the soft tissues of the lower limbs,

          4. Operable disease (first-line treatment or neo-adjuvant therapy),

          5. ECOG, Performance Status ≤ 2,

          6. Decision of surgery validated in Multidisciplinary Consultation Meeting,

          7. Reports of the non-opposition documented in the patient file before any procedure
             specific to the study,

          8. Affiliation to system of Social Security (accordance with article L1121-11 of the Code
             of Public Health).

        Exclusion Criteria:

          1. Metastatic disease from the onset or relapse

          2. Participation in another study involving a similar geriatric assessment.

          3. Geographic, familial, social, psychological or psychiatric factors that make the
             patient incapable of undergoing the study's follow-up and procedures.

          4. Persons deprived of liberty or placed under judicial protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cécile MERTENS, MD</last_name>
    <phone>0556337828</phone>
    <email>c.mertens@bordeaux.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Simone MATHOULIN-PELISSIER, MD,PhD</last_name>
    <email>s.mathoulin@bordeaux.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile MERTENS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Cécile MERTENS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2017</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Soft Tissue Sarcoma</keyword>
  <keyword>Surgery</keyword>
  <keyword>Functional Impact</keyword>
  <keyword>Elderly Patient</keyword>
  <keyword>Geriatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

